Keywords: medarex/medimmune, begin, dosing, ph, medi-545, trial, medarex

Medarex/MedImmune begin dosing in Ph I MEDI-545 trial

Article | 24 April 2006

Print This

Medarex says that its partner, fellow US drugmaker MedImmune, has begun dosing patients in a Phase I clinical trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in